• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • UK / Ireland

AIFM: The end of a long road

Sign marking the end of a road
  • John Bakie
  • 26 October 2010
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

With today’s news that European Parliament negotiators have agreed on the final text of the Alternative Investment Fund Manager’s Directive (AIFM), the private equity industry can look forward to greater certainty about the regulatory environment going forward. John Bakie takes a look back at the short but substantial history of the AIFM.

Just 18 months ago, in the midst of one of the worst recessions in living memory, the AIFM was proposed to enable greater scrutiny of private equity and hedge funds and protect investors. The original draft was, understandably, rather worrying for private equity fund managers, as it would place substantial restrictions on their investors and the way they run portfolio companies.

Industry professionals were worried by a number of proposals, including suggestions their portfolio companies would need to disclose commercially sensitive information, that non-EU funds would no longer be able to market to European investors, and high capital adequacy requirements. Fortunately, many of the original suggestions turned out to be rather tame when details were published. Despite initial fears that funds would need large capital reserves, proposals suggested they hold just €125,000 in reserve, increasing modestly when a fund reached €250m. Similarly, many disclosure rules were not any more onerous than those already implemented by many member states.

However, the issue of rules regarding non-EU funds was a major point of contention, and one that has continually held up the Directive's implementation until reaching a breakthrough last week. The initial rules would place heavy restrictions on any alternative investment fund not domiciled in the EU marketing its products to EU investors, a move which many felt would be highly damaging to the European private equity industry.

Following numerous delays and major disagreements between the European Commission and the European Parliament, the current Belgian Presidency proposed an amendment, which would ultimately bring the long saga of the AIFM Directive to an end. It suggested that third country funds should be able to obtain a "passport" if they met certain criteria, enabling them to market their services in the EU, while still giving European regulators some control.

While the amendment was initially met with hostility by both France and Germany, it was eventually agreed to by finance ministers last week. Now that European Parliament negotiators have also accepted the final text of the Directive, it looks set to be formally approved on 11 November.

While it may seem the industry has now reached the end of a very long road, the journey may be just beginning. Over the next two years, member states and the industry will need to ready themselves for the new regulatory regime, to ensure business can continue after the 2013 implementation deadline.

The debate over the Directive's worth will, no doubt, rage on. Just today, the British Venture Capital Association (BVCA) has continued to object to the AIFM, saying: "This remains a defective Directive. The EU has taken a hostile interest in the wrong industry at the wrong time and for the wrong reasons."

 

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • UK / Ireland
  • Southern Europe
  • France
  • Benelux
  • DACH
  • Nordics
  • Regulation
  • AIFM Directive

More on UK / Ireland

Fund closes in US dollars
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • Funds
  • 05 September 2023
Clinical trials and biotechnology
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • Buyouts
  • 04 September 2023
Public sector software
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • Exits
  • 04 September 2023
EMEA Public to Private M&A
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • Investments
  • 04 September 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013